VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, December 31, 2025

Stock Comparison

ANSYS, Inc. vs Sanofi

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

ANSYS, Inc.

ANSS · Nasdaq Global Select Market

Market cap (USD)
SectorTechnology
CountryUS
Data as of2025-12-31
Moat score
68/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into ANSYS, Inc.'s moat claims, evidence, and risks.

View ANSS analysis

Sanofi

SAN · Euronext Paris

Market cap (USD)
SectorHealthcare
CountryFR
Data as of2025-12-30
Moat score
74/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Sanofi's moat claims, evidence, and risks.

View SAN analysis

Comparison highlights

  • Moat score gap: Sanofi leads (74 / 100 vs 68 / 100 for ANSYS, Inc.).
  • Segment focus: ANSYS, Inc. has 3 segments; Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
  • Moat breadth: ANSYS, Inc. has 7 moat types across 3 domains; Sanofi has 5 across 3.

Primary market context

ANSYS, Inc.

Core Multiphysics Simulation Platform (CAE)

Market

Multiphysics engineering simulation (CAE) software

Geography

Global

Customer

Enterprises and academia

Role

Engineering design, verification, and validation software

Sanofi

Pharma (Prescription Medicines)

Market

Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)

Geography

Global

Customer

Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)

Role

Research-based drug developer, manufacturer, and marketer

Revenue share

79.8%

Side-by-side metrics

ANSYS, Inc.
Sanofi
Ticker / Exchange
ANSS - Nasdaq Global Select Market
SAN - Euronext Paris
Market cap (USD)
n/a
n/a
Sector
Technology
Healthcare
HQ country
US
FR
Primary segment
Core Multiphysics Simulation Platform (CAE)
Pharma (Prescription Medicines)
Market structure
Oligopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
68 / 100
74 / 100
Moat domains
Demand, Network, Legal
Legal, Supply, Demand
Last update
2025-12-31
2025-12-30

Moat coverage

Shared moat types

No overlap yet.

ANSYS, Inc. strengths

Suite BundlingSwitching Costs GeneralData Workflow LockinDesign In QualificationDe Facto StandardEcosystem ComplementsCompliance Advantage

Sanofi strengths

Regulated Standards PipeIP Choke PointLearning Curve YieldBrand TrustDistribution Control

Segment mix

ANSYS, Inc. segments

Full profile >

Core Multiphysics Simulation Platform (CAE)

Oligopoly

n/a

Electronics & Semiconductor Simulation (EDA-adjacent)

Oligopoly

n/a

Digital Mission Engineering & Safety-Critical Tooling

Competitive

n/a

Sanofi segments

Full profile >

Pharma (Prescription Medicines)

Oligopoly

79.8%

Vaccines

Oligopoly

20.2%

Opella (Consumer Healthcare - Sanofi minority stake)

Competitive

n/a

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.